Form 4 for KOD Kodiak Sciences Inc.
Accepted 2026-04-02 20:26:22 ET · period of report 2026-04-02 · accession 0001754045-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-04-02 20:26 | 2026-04-02 | KOD | BORGESON JOHN A. | CFO | M - OptEx | $1.04 | +30.0K | 213.3K | +16% | +$31.2K |
| DMT | 2026-04-02 20:26 | 2026-04-02 | KOD | BORGESON JOHN A. | CFO | S - Sale+OE | $39.92 | -30.0K | 183.3K | -14% | -$1.20M |
| DT | 2026-04-02 20:26 | 2026-04-02 | KOD | BORGESON JOHN A. | CFO | M - OptEx | $0.00 | -30.0K | 58.6K | -34% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-02 | M | A | 30,000 | $1.04 | 213,316 | D | — | — | |
| 2 | Common | Common Stock | 2026-04-02 | S | D | 12,692 | $39.14 | 200,624 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 29, 2025. (F2) The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $38.68 to $39.67, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes. |
| 3 | Common | Common Stock | 2026-04-02 | S | D | 12,477 | $40.29 | 188,147 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 29, 2025. (F3) The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $39.68 to $40.67, inclusive. |
| 4 | Common | Common Stock | 2026-04-02 | S | D | 4,231 | $40.88 | 183,916 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 29, 2025. (F4) The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $40.68 to $41.67, inclusive. |
| 5 | Common | Common Stock | 2026-04-02 | S | D | 600 | $41.77 | 183,316 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 29, 2025. (F5) The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $41.69 to $41.91, inclusive. |
| 6 | Derivative | Stock Option (Right to Buy) | 2026-04-02 | M | D | 30,000 | $0.00 | 58,614 | D | $1.04 · — to 2026-06-22 | 30,000 Common Stock | (F6) The shares subject to this option are fully vested. |